Sign in

Private company

Carmot Therapeutics (United States)

Logo: carmot.us3

Carmot Therapeutics (United States) is an American pharmaceutical preparations company based in San Francisco.1 It was founded in 2008.1

Last updated Oct 21, 2026.

Overview

Jan 1, 2008Founded1
  • IndustryPharmaceutical Preparations1
  • HeadquartersSan Francisco1
  • Websitecarmot.us
  • Incorporated inDE4
  • Business address740 Heinz Avenue, Berkeley, Ca 947104
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Carmot Therapeutics (United States) image from its website
Image: carmot.us3

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive Officer, DirectorHeather K. Turner named Jun 6, 20235
  • Executive Officer, DirectorStig K. Hansen named Aug 8, 20226
  • DirectorAetna Wun K. Trombley named Aug 8, 2022 to Jun 6, 20235
  • DirectorAnne K. Phillips, M.D. named Jun 6, 20235
  • DirectorPeter K. Svennilson named Aug 8, 2022 to Jun 6, 20235
  • DirectorStig K. Hansen, Ph.D. named Jun 6, 20235
  • DirectorTim K. Kutzkey named Aug 8, 2022 to Jun 6, 20235
  • DirectorTimothy K. Garnett named Aug 8, 2022 to Jun 6, 20235

Timeline

  1. Jan 1, 2008Founded Founded1

Filings

7 filings to the SEC since October 2021: 2 private raises, 5 other. The latest 7:

  1. Dec 11, 2023RW EDGAR
  2. Nov 20, 2023S-1/A EDGAR
  3. Nov 17, 2023S-1 EDGAR
  4. Nov 1, 2023DRS/A EDGAR
  5. Sep 28, 2023DRS EDGAR
  6. Jun 6, 2023D EDGAR
  7. Aug 8, 2022D EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$310.7M 2022–2023
Money received by yearMoney received by year, 2022–2023: $310.7M in all. Private raises (Form D) $310.7M.$0$50M$100M$150M$200M2022 · Private raises (Form D): $160.7M20222023 · Private raises (Form D): $150.0M2023
Figures by year
YearPrivate raises (Form D)Total
2023$150.0M$150.0M
2022$160.7M$160.7M

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

  1. May 24, 2023Raised $150 million in a private offering of equity5 Form D: 25 investors so far Form D
  2. Jul 25, 2022Raised $160.7 million in a private offering of equity6 Form D: 15 investors so far Form D

SEC filer profile

How Carmot Therapeutics (United States) is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARCarmot Therapeutics Inc.2
  • CIK0001490109
  • Employer ID (EIN)26-18726842
  • Incorporated inDelaware2
  • Fiscal year endsDecember 312
  • Industry code (SIC)2834 Pharmaceutical Preparations2
  • Business address740 Heinz Avenue, Berkeley, CA 947102
  • Phone(888) 402-46742
  • On EDGAR sinceApr 23, 20102
  • Filings11 in all: D (6), DRS (1), DRS/A (1), RW (1), S-1 (1), S-1/A (1)2

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6